Astera Labs (NASDAQ:ALAB) Issues Q3 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its third quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.160-1.210 for the period, compared to the consensus earnings per share estimate of 0.730. The company issued revenue guidance of $540.0 million-$560.0 million, compared to the consensus revenue estimate of $410.3 million.

Astera Labs Price Performance

Shares of ALAB traded up $16.44 during mid-day trading on Thursday, hitting $334.87. The company’s stock had a trading volume of 2,610,714 shares, compared to its average volume of 5,568,058. The firm has a 50-day moving average price of $360.98 and a 200 day moving average price of $233.52. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a market capitalization of $57.40 billion, a price-to-earnings ratio of 165.73, a PEG ratio of 4.19 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 20.46%. The business’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts anticipate that Astera Labs will post 1.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on ALAB shares. Needham & Company LLC raised their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday. Bank of America upped their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Royal Bank Of Canada lifted their price target on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $325.25.

Insider Activity

In other news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 1,244,395 shares of company stock valued at $358,865,571. Insiders own 10.40% of the company’s stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q2 results exceeded expectations. Revenue rose 104.5% year over year to a record $392.4 million, surpassing the $360.9 million consensus estimate. Adjusted EPS of $0.80 also topped expectations of $0.69 and increased from $0.44 a year earlier. Astera Labs Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Q3 guidance was substantially above analyst forecasts. Astera Labs projected revenue of $540 million to $560 million and EPS of $1.16 to $1.21, compared with consensus estimates of approximately $410.3 million in revenue and $0.73 EPS. The outlook implies roughly 40% sequential revenue growth. Astera Labs Q2 Earnings Beat on PCIe 6 and Scorpio Strength
• Positive Sentiment: AI-related product momentum is strengthening. PCIe 6 products generated more than half of sales, while the Scorpio X-Series 320-lane fabric switch entered volume production one quarter ahead of schedule. Management expects the Scorpio ramp to be the primary driver of third-quarter growth. ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
• Positive Sentiment: Analyst sentiment improved. Needham raised its price target from $260 to $425 and maintained a Buy rating, while other analysts lifted forecasts after the earnings beat. Needham Raises Astera Labs Price Target
• Neutral Sentiment: Astera Labs is benefiting from the broader AI capital-spending cycle as a supplier of connectivity and signal-conditioning components—the “picks and shovels” of increasingly dense AI systems.
• Negative Sentiment: Despite strong fundamentals, one Seeking Alpha analysis downgraded the stock, arguing that the “easy money” has passed and that its elevated valuation leaves less room for error. With a reported P/E ratio above 165, expectations remain demanding. Astera Labs Rating Downgrade

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALAB. Great Valley Advisor Group Inc. lifted its holdings in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares in the last quarter. National Bank of Canada FI grew its position in Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Prosperity Wealth Management Inc. grew its stake in Astera Labs by 4.1% in the third quarter. Prosperity Wealth Management Inc. now owns 4,300 shares of the company’s stock valued at $842,000 after purchasing an additional 168 shares in the last quarter. Finally, State of Wyoming increased its holdings in Astera Labs by 29.1% during the fourth quarter. State of Wyoming now owns 826 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.